Back
Corporate News
Cohance Lifesciences halts trading for insiders pending financial results declaration
28-Sep-2026, 03:04
Cohance Lifesciences Limited, formerly Suven Pharmaceuticals Limited, will close its trading window for designated persons and their immediate relatives from October 1, 2026, until 48 hours after the declaration of unaudited financial results for the quarter and half year ending September 30, 2026, in compliance with SEBI regulations.
